2
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Prostatic Neoplasms
25
Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Breast Neoplasms
13
Colonic Neoplasms
9
Uterine Cervical Neoplasms
7
Lung Neoplasms
6
Colorectal Neoplasms
6
Urinary Bladder Neoplasms
5
Melanoma
5
Leukemia, Myeloid, Acute
5
Carcinoma, Renal Cell
5
Uterine Cervical Dysplasia
4
Lymphoma, Large B-Cell, Diffuse
4
Esophageal Neoplasms
4
Brain Neoplasms
4
Thrombocythemia, Essential
3
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Polycythemia Vera
3
Papillomavirus Infections
3
Oropharyngeal Neoplasms
3
Neuroblastoma
3
Mouth Neoplasms
3
Liver Neoplasms
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hodgkin Disease
3
Glioma
3
Gallbladder Neoplasms
3
Carcinoma, Hepatocellular
3
Interventions
Propranolol
2
daratumumab
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Simvastatin
1
Observation
1
DNA
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemangioma, Cavernous, Central Nervous System
×
Watchful Waiting
×
Clear all
NCT04467489
2025-08-11
Biomarkers of CASH
University of Chicago
Active not recruiting
1,040 enrolled